Issue link: https://maltatoday.uberflip.com/i/1467182
maltatoday | SUNDAY • 8 MAY 2022
10
COMMERCIAL
The most valuable lessons in investing
IN life, saving money is vital, but
it is only one piece of the puzzle.
Investing is a good way to put
one's money to work and po-
tentially grow one's wealth as it
is never too late for one to start
investing.
Medina Asset Management
is an investment company li-
censed by MFSA. Medina's
mission is to protect and grow
the wealth of its clients. This
is achieved by helping families
and businesses to save and in-
vest wisely, whilst always put-
ting them and ethics first.
Christiana Teuma will provide
a thorough explanation of the
fundamental financial concepts
used in finance. The definitions
of individual stocks and bonds
will be followed by an explana-
tion of a portfolio of funds. She
will outline the current events
in the financial market, such
as high inflation, rising interest
rates, and the effects of the on-
going war in Ukraine. She says:
"Achieving long-term financial
objectives entails embracing
the risk-reward trade-off and
comprehending the historical
dynamics of various types of in-
vestments".
The salient takeaways from
this session will be covered by
Ann Marie Lia, where she will
go through the main principles
for investment success. To have
a better chance at investment
success, one has to focus on
what s/he can control.
It is very easy, and very tempt-
ing, to just focus on the market,
the performance of individual
funds, or the economy, which
can lead one to overlook the
basic principles of investment
success.
Lastly, Professor Falzon will
provide a brief history of the
stock market, covering market
uptrends and declines while
highlighting the critical lessons
of investing which is the fun-
damental message of this BNI
Business Briefing.
One has to keep in mind that
many of the market declines of
the last decades are becoming
faded memories and long-term
investors know that the mar-
ket and the economy general-
ly recover over time. To give
a real-life example, during the
2008 financial decline, the US
market declined 48% and many
investors sold off their hold-
ings. However, after the mar-
ket bottomed in March 2009, it
eventually recovered to its for-
mer levels and well beyond. In
fact, between the beginning of
the bull market in March 2009
and the end of January 2022,
the US stock market increased
6.4 times (15.4% increase per
annum), which means that
for every €100,000 invested in
March 2009, this would have
grown to €640,000 by the end of
January 2022.
Prof. Falzon says: "Investors
should be positioned for such
a rebound, as in the long term
these short-term fluctuations
do not affect one's investments."
The Malta BNI Business Brief-
ings (BBB) is a series of free on-
line short sessions organised by
Malta BNI that are held remote-
ly at lunchtime via Zoom.
BNI is the largest and most
successful business networking
organisation with Members and
Chapters in over 74 countries.
Visitors are welcome to join
these three speakers from Medi-
na Asset Management Ltd., a
BNI La Valette Chapter mem-
ber, to learn about investments
and as to why the stock market
should be viewed as a vehicle to
compound one's wealth and be
better off financially.
Registration for the upcoming
business briefing is free and may
be done at https://bit.ly/3vt-
NUE8. Contact Carmel Bonello
at carmelbonello2020@outlook.
com, David Bullock at david.
malta.bni@gmail.com, or Vivi-
ana Premazzi at viviana@gmd-
malta.com for additional infor-
mation about this free event.
Joseph Falzon (left), Ann Marie Lia
(centre) and Christiana Teuma (right)
IN a world first, Malta-based
innovation consultancy
CLEANTECH360 is delighted
to announce that the unique
Attomarker Antibody Immuni-
ty Test is now available at Rem-
edies Clinic.
This near-patient, rapid di-
agnostic test – the first of its
kind to provide a measure of
COVID-19 antibody immuni-
ty and how long it is likely to
last – will help individuals un-
derstand their personal COVID
risk and to take more informed
health decisions. The test can
also establish antibody immuni-
ty thresholds for different vari-
ants, helping to maintain an ef-
fective vaccine shield to control
infection and reduce the preva-
lence of the virus.
For the first time, individuals
can know whether they have
high antibody levels and can
approach a "normal" daily life.
More importantly, we can iden-
tify poor responders or those
with a rapidly waning vaccine
or booster effect, so they can
protect themselves, ideally be-
fore falling below the 'edge of
immunity.' This could become
a vital test for the elderly, more
vulnerable and regular travel-
lers.
Attomarker's test is the only
rapid, quantitative, near-patient
Antibody Immunity Test in the
world that can tell you the level
and type of antibodies you have
developed as a result of vaccina-
tion and, if relevant, from natu-
ral infection. It can also predict
how long your personal anti-
body immunity is likely to last
into the future, until you reach
what is termed 'the edge of im-
munity.'
Attomarker's Antibody Im-
munity test measures IgG anti-
bodies to Nucleocapsid, Spike,
Spike Omicron, RBD, and pro-
vides a CRP result (an impor-
tant measure of inflammation).
It is hoped that, by maintaining
an Antibody Immunity Shield,
it will be possible to stop more
people from getting infected in
the first place. If we can prevent
more infections, less people
should be at risk from the poten-
tially life-altering consequences
of long-Covid.This is just the
first of a number of important
medical products currently in
development by Attomarker.
The company is already using
its unique technology platform
to research and develop further
tests: including biomarkers for
liver health, food allergies and
fertility. Provided trials are
successful, CLEANTECH360
expects to announce the avail-
ability of these tests in Malta in
due course.
Attomarker Antibody Immu-
nity Test is exclusively available
in Malta at Remedies.
To book a test please call or
email: Remedies Clinic Tel:
2149 8000. For more informa-
tion and interview opportuni-
ties, please contact Teuta Oruçi
on